This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hadasit Medical Research Services and Development Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Ehud Ziv
Introduction
Ehud Ziv is an accomplished inventor based in Moza Ilit, Israel. He has made significant contributions to the field of medical research, particularly in the area of diabetes prevention and treatment. His work focuses on the development of innovative pharmaceutical compositions aimed at combating insulin resistance and type 2 diabetes.
Latest Patents
Ehud Ziv holds a patent for "Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes." This invention provides peptides and peptide analogs capable of inhibiting the activity of protein kinase C. The patent discloses the use of such peptides and analogs for the preparation of pharmaceutical compositions and methods for the prevention, delay, suppression, or treatment of type 2 diabetes using these compositions. He has 1 patent to his name.
Career Highlights
Ehud Ziv is associated with Hadasit Medical Research Services and Development Ltd., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of diabetes, a condition affecting millions worldwide.
Collaborations
Ehud Ziv has collaborated with notable colleagues, including Eleazar Shafrir and Hadas Reuveni. These partnerships have contributed to the advancement of his research and the development of effective treatments.
Conclusion
Ehud Ziv's innovative work in the field of diabetes prevention showcases his dedication to improving health outcomes through scientific research. His contributions are vital in the ongoing battle against type 2 diabetes.